The impact of anxiety and affective disorders on breast cancer screening in women in Puerto Rico
PLOS One · 2026
DOI: 10.1371/journal.pone.0357375 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Marjorie Vázquez-Roldán und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico. Hauptthemen laut MEDLINE: Breast Neoplasms, Mood Disorders, Early Detection of Cancer, Anxiety. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIMHD NIH HHS, National Program of Cancer Registries.
Abstract (Originalsprache)
Background
Breast cancer is the most common cancer among women globally. Early detection using mammography is crucial for improving outcomes and reducing aggressive treatment. Factors such as age, comorbidities, insurance coverage, and mental health conditions may influence screening behavior. Limited research exists on the relationship between mental health and breast cancer screening in Puerto Rico. This study examines factors associated with early detection among women aged 50 and older diagnosed with breast cancer and coexisting anxiety or affective disorder.
Methods
We conducted a retrospective cohort study using data from the Puerto Rico Central Cancer Registry linked with the Health Insurance Linkage Database. Multivariable logistic regression was used to estimate adjusted odds ratios (AOR) to describe the relationship between having anxiety or affective disorder with the use of mammography and the stage at diagnosis. Cox proportional hazards model was used to assess the association between mental health diagnosis and risk of death, respectively.
Results
Among 4,708 eligible women, 376 (8.0%) had an anxiety or affective disorder. Overall, 90.0% received a mammogram within 24 months prior to diagnosis, and 35.1% were diagnosed at a late stage. Women with anxiety or affective disorder were 57.0% more likely to have undergone screening (AOR 1.57, 95% confidence interval [CI]: 1.01–2.43; p = 0.046). These disorders were not significantly associated with cancer stage at diagnosis (AOR 0.86, 95% CI 0.68–1.09; p = 0.208) and did not increase the risk of death within 5 years (Adjusted Hazard Ratio [AHR] 1.01, 95% CI: 0.76–1.35; p = 0.094).
Conclusion
In our study, anxiety or affective disorders were associated with increased mammography use but not with earlier cancer stages. Further research is needed on severe mental illness and the bidirectional relationship between cancer and mental health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
- Department of Health Services Administration, Graduate School of Public Health, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico.
- Auxiliary Secretariat for Public Health Surveillance & Protection, Puerto Rico Department of Health, San Juan, Puerto Rico.
ORCID-Profile: Marjorie Vázquez-Roldán, Karen J Ortiz-Ortiz, Axel Gierbolini-Bermúdez
Förderung
- NIGMS NIH HHS
- NIMHD NIH HHS
- National Program of Cancer Registries
- National Institutes of Health
Zitieren
APA
Vázquez-Roldán, M., Ortiz-Ortiz, K. J., Millán-Pérez, L. I., Gierbolini-Bermúdez, A., & Ríos-Motta, R. (2026). The impact of anxiety and affective disorders on breast cancer screening in women in Puerto Rico. PLOS One. https://doi.org/10.1371/journal.pone.0357375
Vancouver
Vázquez-Roldán M, Ortiz-Ortiz KJ, Millán-Pérez LI, Gierbolini-Bermúdez A, Ríos-Motta R. The impact of anxiety and affective disorders on breast cancer screening in women in Puerto Rico. PLOS One. 2026. doi:10.1371/journal.pone.0357375
BibTeX
@article{VzquezRoldn2026,
author = {Vázquez-Roldán, Marjorie and Ortiz-Ortiz, Karen J and Millán-Pérez, Liza I and Gierbolini-Bermúdez, Axel and Ríos-Motta, Ruth},
title = {The impact of anxiety and affective disorders on breast cancer screening in women in Puerto Rico},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0357375}
}
EUVIMED